Amgen beats Q1 expectations, issues solid full-year outlook

Investing.comMay 1, 2025 8:42 PM

View all comments（0）



Investing.com - Amgen Inc (NASDAQ:AMGN) reported better-than-expected first-quarter results, driven by strong demand for its products globally.

The biotechnology company posted adjusted earnings per share of $4.90, surpassing analyst estimates of $4.29. Revenue rose 9% YoY to $8.15 billion, slightly above the consensus forecast of $8.09 billion.

"Demand for our products was strong globally in the first quarter. Ongoing new product launches and successful Phase 3 trial results for several products make us feel confident in our long-term growth prospects," said Robert A. Bradway, chairman and chief executive officer.

Product sales grew 11%, primarily driven by 14% volume growth, partially offset by 6% lower net selling price. U.S. sales increased 14%.

Fourteen products delivered at least double-digit sales growth in the quarter, including Repatha, BLINCYTO, and TEZSPIRE. The company’s newly launched IMDELLTRA generated $81 million in sales.

For the full year 2025, Amgen said it expects adjusted EPS of $20.00-$21.20, versus the consensus of $20.63, and revenue of $34.3-$35.7 billion, versus the consensus of $35.102 billion.

The company generated $1.0 billion of free cash flow in Q1, up from $0.5 billion in the same period last year.

Amgen’s shares were flat in after-hours trading following the earnings release.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

SK Hynix Surges Over 4% as Q3 Results Hit Record High, Returning $75 Billion to Shareholders

SK Hynix reported a record-breaking Q3 operating profit while announcing a massive 100 trillion won (approximately $75 billion) shareholder return plan, sending its stock price surging 4%.

Today’s Market Recap: $63 Billion Anthropic Compute Financing Lifts Chip Stocks, Broadcom Gains 4%, CRWV Rises Nearly 8%, Boeing Falls Over 10%

TradingKey - On October 27, Eastern Time, all three major U.S. stock indexes closed higher, with the Nasdaq and the S&P 500 gaining for the second consecutive trading day. AI-related stocks continued to lead the rally, while a $63 billion computing power financing deal involving Broadcom (AVGO) lift

KOSPI Tops 5,800, Kioxia Jumps Over 4% as SK Hynix Revenue and Profit Hit Record Highs

The KOSPI surged over 3%, Kioxia jumped 4%, Samsung and SoftBank joined the rally, and SK Hynix unveiled a massive 100 trillion KRW in shareholder returns.

US Stocks Close: Nasdaq Rises Over 1%, Philadelphia Semiconductor Index Gains Over 3%; Chip Stocks Extend Rally, CoreWeave Gains Nearly 8%

On Tuesday, October 27, Eastern Time, U.S. stocks moved higher, with chip stocks extending their rally to drive the Nasdaq to lead the gains. Amid falling oil prices, investors continued to assess a heavy slate of corporate earnings reports while focusing on the Federal Reserve's interest rate meeting. At the close, the Dow Jones Industrial Average rose 0.03% to 52,377.57 points; the Nasdaq Composite Index gained 1.18% to 26,477.81 points; and the S&P 500 Index advanced 0.60% to 7,722.60 points.

Amazon Q3 Earnings Preview: AWS Growth Expected to Rise to 41%, Wall Street Top Price Target $400

TradingKey - Amazon (AMZN) will release its third-quarter 2026 financial results after the U.S. market close on October 29, Eastern Time, and hold an earnings conference call at 17:00 on the same day.

Featured Tools